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ABSTRACT 
The long surface antigen (L-HBsAg) of hepatitis B virus (HBV) plays a central role in the 
production of infectious virions. During HBV morphogenesis, both the PreS and S domains 
of L-HBsAg form docking sites for the viral nucleocapsids. Thus, a compound that disrupts 
the interaction between the L-HBsAg and nucleocapsids could serve as a therapeutic agent 
against the virus based upon inhibition of morphogenesis. Synthetic peptides correspond to 
the binding sites in L-HBsAg inhibited the association of L-HBsAg with core antigen 
(HBcAg). A synthetic peptide carrying the epitope for a monoclonal antibody to the PreS1 
domain competed weakly with L-HBsAg for HBcAg, but peptides corresponding to a linear 
sequence at the tip of the nucleocapsid spike did not, showing that the competing peptide 
does not resemble the tip of the spike. 
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